Table 1

Some characteristics of ALL patients and controls in the study population
Characteristics Subgroups ALL Controls
Total number of subjects 543 529
Gender n (%) Male 308 (56.7) 305 (57.7)
Female 235 (43.3) 224 (42.3)
Age at diagnosis, years (mean±SD) 6.4±4.2 16.1±12.4
Number of subjects n (%) <1 year 8 (1.5) -
1-10 years 422 (77.7) 200 (37.8)
>10 years 107 (19.7) 329 (62.2)
N/D 6 (1.1) -
Risk group n (%) LR 96 (17.7) -
MR 309 (56.9) -
HR 55 (10.1) -
Protocols n (%) 90 131 (24.1) -
95 250 (46.0)
2002 120 (22.1) -
N/D 42 (7.7)
Immunphenotype n (%) B-ALL 390(71.8) -
T-ALL 78 (14.4) -
Cytogenetics n (%) Hyperdiploidy 79 (14.5) -
Overall survival n (%) 516*  414 (85.5)* -
Event free survival n (%) 516* 418 (81.0)* -

N/D: no data available; LR: Low risk, MR: Medium risk; HR: High risk, *see details in the text.

Lautner-Csorba et al.

Lautner-Csorba et al. BMC Medical Genomics 2012 5:42   doi:10.1186/1755-8794-5-42

Open Data